“…The main guiding principles have been to use some tests that can be related to the extensive neuropsychological literature in animals and to employ tests that can be broken down into their cognitive components in order to define more readily which functions are impaired and which are spared. The battery has now been used quite extensively in the testing of patients with Alzheimer's disease and other forms of dementia (Sahakian et al, 1988Sahgal et al, 1991Sahgal et al, ,1992, patients with basal ganglia disorders such as Parkinson's disease (Downes et al, 1989;Owen et al, 1992, Korsakoff's syndrome (Joyce & Robbins, 1991), depression (Abas et al, 1990;Beats et al, 1996), schizophrenia , HIV-positive patients , and children with minimal learning disabilities or autism (Hughes et al, 1994). The tests have also been validated in neurosurgical patients with excisions of the temporal or frontal lobes and amygdalohippocampectomy (Owen et al, 1995).…”